Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies

Raquel Yotti1,2, Christine E Seidman3,4,5, Jonathan G Seidman3

  • 1Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain;

Insights

Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) stem from genetic variants affecting heart muscle proteins. New research reveals molecular mechanisms in HCM related to relaxation and energy conservation, and in DCM, titin variants impairing muscle development, paving the way for new treatments.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Molecular Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) are prevalent heart muscle diseases.
  • These conditions result from pathogenic variants in genes encoding sarcomere proteins.
  • HCM involves unexplained cardiac hypertrophy with altered contractility and relaxation; DCM features enlarged ventricles and impaired function.

Purpose of the Study:

  • To review recent analyses offering new insights into the molecular mechanisms underlying HCM and DCM.
  • To highlight novel pathophysiologic mechanisms discovered for these cardiomyopathies.
  • To identify potential new pharmacological targets and cardioprotective strategies.

Main Methods:

  • Review of recent scientific analyses and studies on hypertrophic cardiomyopathy and dilated cardiomyopathy.
  • Focus on molecular mechanisms, genetic variants, and their functional consequences.
  • Analysis of findings related to sarcomere protein gene mutations.

Main Results:

  • HCM studies emphasize the role of disturbed conformational changes during relaxation and energy conservation due to mutations.
  • DCM studies reveal a high prevalence of truncating variants in titin.
  • These titin variants impair contractile function by disrupting sarcomerogenesis.

Conclusions:

  • Understanding these new pathophysiologic mechanisms is crucial for advancing cardiovascular medicine.
  • Identified mechanisms provide opportunities for developing novel pharmacological therapies.
  • Future cardioprotective strategies can be informed by these molecular insights into HCM and DCM.

Related Concept Videos

The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each...
15.5K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
531
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
459
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
507
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
747